GE HealthCare Technologies Future Growth
Future criteria checks 1/6
GE HealthCare Technologies is forecast to grow earnings and revenue by 13.4% and 5.4% per annum respectively. EPS is expected to grow by 13.4% per annum. Return on equity is forecast to be 18.6% in 3 years.
Key information
13.4%
Earnings growth rate
13.4%
EPS growth rate
Medical Equipment earnings growth | 17.5% |
Revenue growth rate | 5.4% |
Future return on equity | 18.6% |
Analyst coverage | Good |
Last updated | 31 Jul 2024 |
Recent future growth updates
Recent updates
GE HealthCare: Near-Term Risks, But Some Interesting Longer-Term Opportunities
Jul 07Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?
May 21GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)
May 02GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price
Apr 25GE Vernova: An Interesting Stalwart To Ride The Energy Transition
Apr 02GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive
Mar 25GE HealthCare Technologies' Roar Higher Isn't Over Yet
Mar 09GE HealthCare Technologies: Stable Business, But Future Upside Seems Limited
Feb 14GE HealthCare Q4 Earnings: Growth Lagging The Market
Feb 06Why GE HealthCare May Be Up To 50% Undervalued
Jan 11GE HealthCare Technologies (NASDAQ:GEHC) May Have Issues Allocating Its Capital
Jan 05GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Could Be 29% Above Their Intrinsic Value Estimate
Oct 23GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 44% Above Its Share Price
Jun 28Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 22,063 | 2,349 | 2,661 | 3,845 | 14 |
12/31/2025 | 20,972 | 2,097 | 1,742 | 2,884 | 16 |
12/31/2024 | 19,849 | 1,814 | 1,789 | 2,811 | 10 |
6/30/2024 | 19,518 | 1,584 | 1,617 | 2,000 | N/A |
3/31/2024 | 19,495 | 1,574 | 1,663 | 2,052 | N/A |
12/31/2023 | 19,552 | 1,389 | 1,714 | 2,101 | N/A |
9/30/2023 | 19,284 | 1,534 | 1,723 | 2,093 | N/A |
6/30/2023 | 19,038 | 1,643 | 1,701 | 2,065 | N/A |
3/31/2023 | 18,705 | 1,698 | 1,760 | 2,113 | N/A |
12/31/2022 | 18,341 | 1,898 | 1,803 | 2,113 | N/A |
9/30/2022 | 17,992 | 1,914 | 754 | 1,060 | N/A |
6/30/2022 | 17,720 | 1,929 | 724 | 1,016 | N/A |
3/31/2022 | 17,582 | 2,037 | 1,265 | 1,555 | N/A |
12/31/2021 | 17,585 | 2,229 | 1,359 | 1,607 | N/A |
12/31/2020 | 17,164 | 2,007 | 1,428 | 1,687 | N/A |
12/31/2019 | 16,633 | 1,652 | 1,658 | 1,989 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GEHC's forecast earnings growth (13.4% per year) is above the savings rate (2.5%).
Earnings vs Market: GEHC's earnings (13.4% per year) are forecast to grow slower than the US market (14.9% per year).
High Growth Earnings: GEHC's earnings are forecast to grow, but not significantly.
Revenue vs Market: GEHC's revenue (5.4% per year) is forecast to grow slower than the US market (8.5% per year).
High Growth Revenue: GEHC's revenue (5.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GEHC's Return on Equity is forecast to be low in 3 years time (18.6%).